Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
SPARC
₹194.70
₹193.84
₹196.75
₹108.00
₹289.00
Markets Today
Historical Performance
As of 26-08-2026 21:15, Sun Pharma Advanced Research Company Ltd. share price today is ₹0, with a change of ₹-194.46 (-100.00%) from the previous close of ₹194.46. The stock opened at ₹194.5 and traded between ₹193.84 and ₹196.75, with a total traded volume of 305096 shares. The company has a market capitalization of ₹6310.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹289 and ₹108, respectively.
Sun Pharma Advanced Research Company Ltd. valuation metrics include a P/E ratio of 4, EPS of ₹47.86, and book value of ₹4.80. Profitability indicators show ROE of 116.01%. Sun Pharma Advanced Research Company Ltd. has reported revenue of ₹1909.45 Cr and net profit of ₹1584.29 Cr.
Sun Pharma Advanced Research Company Ltd. technical indicators include Day RSI at 35.99, Day MFI at 24.28, Day ADX at 22.34. Additional indicators include Commodity Channel Index (CCI) at -102.4 and Williams %R at -91.66. Momentum indicators show Day MACD at -7.83, Day MACD Signal Line at -7.64, DayATR at 8.09. Rate of Change indicators for Sun Pharma Advanced Research Company Ltd. include ROC125 at 48.58 and ROC21 at -9.52.
Exponential moving averages include EMA5 at ₹195.9, EMA10 at ₹198.4, EMA12 at ₹199.6, EMA20 at ₹204.5, EMA26 at ₹207.4, EMA50 at ₹210.1, EMA100 at ₹198.5, EMA200 at ₹181. Simple moving averages include SMA5 at ₹195.8, SMA10 at ₹197.4, SMA20 at ₹203.9, SMA30 at ₹211.2, SMA50 at ₹225, SMA100 at ₹198.1, SMA150 at ₹174.5, SMA200 at ₹165.
Support levels for Sun Pharma Advanced are placed at First Support ₹191.82, Second Support ₹189.18, Third Support ₹186.36. Resistance levels are seen at First Resistance ₹197.28, Second Resistance ₹200.10, Third Resistance ₹202.74. Sun Pharma Advanced Research Company Ltd. shareholding pattern shows promoter holding at 65.67%, FII holding at 3.9%, DII holding at 0%, public holding at 30.34%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 39.92 | 1,853.22 | 8.45 | 7.86 | 9.64 |
| Operating Expense | 74.23 | 80.28 | 65.32 | 73.75 | 61.97 |
| Operating Profit | -34.31 | 1,772.94 | -56.87 | -65.89 | -52.33 |
| Depreciation | 2.20 | 2.40 | 2.56 | 2.57 | 2.54 |
| Interest | 8.13 | 11.64 | 8.78 | 7.52 | 6.18 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -20.98 | 1,760.70 | -80.57 | -75.97 | -52.03 |
₹194.70
↗ Bullish Moving Average
3
↘ Bearish Moving Average
13
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 65.7 | 65.7 | 65.7 | 65.7 | 65.7 | 65.7 |
| FII | 1.4 | 1.5 | 1.8 | 2 | 2 | 3.9 |
| DII | 1.2 | 0.9 | 1 | 0.8 | 0.9 | 0.1 |
| Public | 31.8 | 28.4 | 31.5 | 31.5 | 31.4 | 30.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.51 L | 3.31 L | 45.56% |
| Week | 2.15 L | 4.85 L | 44.19% |
| 1 Month | 4.18 L | 9.04 L | 46.20% |
| 6 Month | 10.54 L | 42.18 L | 25.00% |
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Profit making Companies with High ROCE and Low PE
Newly Affordable Stocks with Good Financials and Durability (subscription)
Undervalued Growth Stocks
Jim Slater's Zulu Principle (Discover Growth Stocks)
Mid-range Performer (DVM)
Rising Net Cash Flow and Cash from Operating activity
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock with Low PE (PE < = 10)
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹2,105.20 | ₹1,121.20 | ₹1,490.20 | ₹1,488.20 | ₹4,175 | ₹766.10 |
| % Change | 0.38% | -0.53% | 0.66% | -1.84% | -0.05% | 2.83% |
| Revenue TTM (₹ Cr) | ₹1,479.07 | ₹675.61 | ₹691.72 | ₹1,543.34 | ₹949.80 | ₹4,501.61 |
| Net Profit TTM (₹ Cr) | ₹199.03 | ₹182.64 | ₹126.37 | ₹-48.62 | ₹266 | ₹291.72 |
| PE TTM | 64.40 | 69.70 | 54.00 | -357.60 | 36.20 | 40.20 |
| 1 Year Return | 97.49 | 90.08 | 106.23 | -19.51 | -19.2 | 55.75 |
| ROCE | 31.54 | 24.22 | 15.60 | 0.59 | - | 11.40 |
Innova Captab Ltd.
₹ 1020.60
-1.90%
Blue Jet Healthcare Ltd
₹ 590.85
+0.29%
Concord Biotech Ltd.
₹ 1546.10
-0.12%
Aarti Pharmalabs Ltd.
₹ 839.00
+0.49%
Supriya Lifescience Ltd.
₹ 784.00
-0.97%
Alivus Life Sciences Ltd.
₹ 1365.00
+1.23%
Cohance Lifesciences Ltd.
₹ 462.00
+3.73%
Eris Lifesciences Ltd.
₹ 1312.90
+0.25%
Syngene International Ltd.
₹ 410.40
+0.98%
Alembic Pharmaceuticals Ltd.
₹ 826.40
+2.90%
Strides Pharma Science Ltd.
₹ 983.50
-0.31%
FDC Ltd.
₹ 347.65
+1.16%
Shilpa Medicare Ltd.
₹ 860.00
-0.18%
Jubilant Pharmova Ltd.
₹ 886.05
-1.18%
Natco Pharma Ltd.
₹ 864.60
-0.19%
Caplin Point Laboratories Ltd.
₹ 2525.00
+2.15%
Marksans Pharma Ltd.
₹ 330.75
+3.85%
Orchid Pharma Ltd.
₹ 973.00
-6.31%
IOL Chemicals and Pharmaceuticals Ltd.
₹ 186.48
+8.19%
Viyash Scientific Ltd.
₹ 263.30
-5.41%
AstraZeneca Pharma India Ltd.
₹ 7150.50
+0.06%
Bliss GVS Pharma Ltd.
₹ 573.70
+2.17%
Sanofi India Ltd.
₹ 3190.00
-0.26%
Morepen Laboratories Ltd.
₹ 97.89
+4.25%
By signing up I certify terms, conditions & privacy policy